WBA:NSQ
Select symbol
- United States
- WBA:NSQNASDAQ
- Germany
- W8A:BERBerlin Stock Exchange
- W8A:DUSDusseldorf Stock Exchange
- W8A:MUNMunich Stock Exchange
- W8A:STUStuttgart Stock Exchange
- W8A:DEUGerman Composite
- W8A:FRAFrankfurt Stock Exchange
- W8A:HAMHamburg Stock Exchange
- W8AX:GERXETRA
- W8A:HANHanover Stock Exchange
- Mexico
- WBA*:MEXMexico Stock Exchange
- Switzerland
- W8A:BRNBerne Stock Exchange
- Austria
- WBA:VIEVienna Stock Exchange
- United Kingdom
- 0LSZ:LSELondon Stock Exchange
- Brazil
- WGBA34:SAOSao Paulo Stock Exchange
- Italy
- 1WBA:MILMilan Stock Exchange
Actions
- Add to watchlist
- Add to portfolio
- Add an alert
Consumer Staples Personal Care, Drug and Grocery Stores
- Price (USD)15.84
- Today's Change-0.02 / -0.13%
- Shares traded8.43m
- 1 Year change-50.39%
- Beta0.7389
Data delayed at least 15 minutes, as of Jun 07 2024 21:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
View our existing alerts
Find More Stocks
Use our equities screener to discover other potential opportunities.
Go to the Equities Screener
ApplyActions
Add to Your Watchlists
Your alerts
You must be a registered user to save alerts. Please sign in or register.
Thanks for letting us know!
Your participation really helps us improve our overall experience.
Got 2 mins? Provide feedback
- 1D
- 1W
- 1M
- 6M
- 1Y
- 3Y
- 5Y
ApplyComparisons
Make up to three selections, then save.0 of 3 selected
0 of 3 selected
- FT NewsFT News
- Press releasesPress releases
- Events & ActivityEvents & Activity
Corporate earnings and results
Profits at Boots soar as beauty sales boom
Pharmacy chain benefits from performance of brands such as Soap & Glory and Liz Earle
Work & Careers
More women make it on to US company boards but fewer reach the C-suite
New data shows progress on diversifying leadership of US companies is one step forward, two steps back
World
FirstFT: Global M&A drought ends as blockbuster deals double in first quarter
Also in today’s newsletter, Sam Bankman-Fried sentencing and the broken market for medicines
World
Courtroom politics
Deadline looms for Trump to raise $464mn appeal case guarantee, while Bankman-Fried set to be sentenced
US Securities and Exchange Commission
The rise of the sloppy SEC filing
We haven’t see this many bad references since [any of our other posts]
UK companies
Next boss warns of stock delays as Red Sea disruption takes toll
UK retailer fears shipping attacks will affect inventory and sales this year
Medical science
New JN. 1 Covid variant gains ground in US ahead of holiday season
Americans’ interest in vaccinations has flagged despite efforts to boost uptake of latest jab
Financials
Berkshire Hathaway after Charlie Munger
Plus, Silver Lake and Michael Dell extract billions from a decade of deals and KKR reorganises its finances
- Walgreens Boots Alliance Schedules Fiscal 2024 Third Quarter Earnings Announcement for June 27
- Walgreens Introduces Summer of Savings
- “Walgreens En Tu Comunidad” Fosters Community in Puerto Rico with Health Fair Aimed to Increase Access and Education of Certain Health Services
- Walgreens Boots Alliance Sells Shares of Cencora for $400 Million of Proceeds
- Walgreens Brand Naloxone Available Online and In Stores This Month
- Walgreens Honors Veterans, Active Duty Military and Their Families with Weekend Discount for Memorial Day Friday, May 24 through Monday, May 27
- Walgreens and Boehringer Ingelheim Are Partnering to Improve Diversity in Clinical Trials
- Walgreens Boots Alliance Provides Summary Notice of Pending and Proposed Settlement of Shareholder Derivative Action
- Walgreens Boots Alliance Declares Quarterly Dividend
- Walgreens Launches Gene and Cell Services as Part of Newly Integrated Walgreens Specialty Pharmacy Business
More ▼
- WBA:NSQ price moved over -1.01% to 15.76
- On date 25 Apr 2024, WBA:NSQ announced a new dividend of amount 0.25 payable on date 25 Apr 2024
Key statistics
On Friday,
52-week range
Today
14.62May 29 202432.89Jun 20 2023
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
| Open | 15.74 |
|---|---|
| High | 15.98 |
| Low | 15.69 |
| Bid | 15.79 |
| Offer | 15.89 |
| Previous close | 15.86 |
| Average volume | 14.11m |
|---|---|
| Shares outstanding | 862.71m |
| Free float | 712.88m |
| P/E (TTM) | -- |
| Market cap | 13.90bn USD |
| EPS (TTM) | -7.00 USD |
| Annual div (ADY) | 1.00 USD |
|---|---|
| Annual div yield (ADY) | 6.31% |
| Div ex-date | May 20 2024 |
| Div pay-date | Jun 12 2024 |
Data delayed at least 15 minutes, as of Jun 07 2024 21:00 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsem*nt or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.
